PDCD1 and neoplasm: High-Dose AA and Anti-PD1 Treatment Combination Leads to Increase in Tumor CD8+ T Cell and Macrophage Infiltration, Enhanced Granzyme B Production by Cytotoxic Cells, and Enhanced Interleukin 12 Production by Antigen-Presenting Cells.